Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cells
Breast cancer prognosis and response to endocrine therapy strongly depends on the expression of the estrogen and progesterone receptors (ER and PR, respectively). Although much is known about ERα gene (ESR1) regulation after hormonal stimulation, how it is regulated in hormone-free condition is not...
| Autores: | , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2018 |
| País: | España |
| Institución: | Universitat Pompeu Fabra |
| Repositorio: | Repositorio Digital de la UPF |
| OAI Identifier: | oai:repositori.upf.edu:10230/42572 |
| Acceso en línea: | http://hdl.handle.net/10230/42572 http://dx.doi.org/10.3390/cancers10100371 |
| Access Level: | acceso abierto |
| Palabra clave: | DNA methylation Breast cancer Endocrine therapy Estrogen receptor Gene expression Progesterone receptor |
| id |
ES_a637541e677d3fb370bfc52d7ea08abc |
|---|---|
| oai_identifier_str |
oai:repositori.upf.edu:10230/42572 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cellsVerde, GaetanoDe Llobet, Lara IsabelWright, Roni H.G.Quilez Oliete, JavierPeiró Sales, SandraLe Dily, FrançoisBeato, MiguelDNA methylationBreast cancerEndocrine therapyEstrogen receptorGene expressionProgesterone receptorBreast cancer prognosis and response to endocrine therapy strongly depends on the expression of the estrogen and progesterone receptors (ER and PR, respectively). Although much is known about ERα gene (ESR1) regulation after hormonal stimulation, how it is regulated in hormone-free condition is not fully understood. We used ER-/PR-positive breast cancer cells to investigate the role of PR in ESR1 regulation in the absence of hormones. We show that PR binds to the low-methylated ESR1 promoter and maintains both gene expression and DNA methylation of the ESR1 locus in hormone-deprived breast cancer cells. Depletion of PR reduces ESR1 expression, with a concomitant increase in gene promoter methylation. The high amount of methylation in the ESR1 promoter of PR-depleted cells persists after the stable re-expression of PR and inhibits PR binding to this genomic region. As a consequence, the rescue of PR expression in PR-depleted cells is insufficient to restore ESR1 expression. Consistently, DNA methylation impedes PR binding to consensus progesterone responsive elements. These findings contribute to understanding the complex crosstalk between PR and ER and suggest that the analysis of ESR1 promoter methylation in breast cancer cells can help to design more appropriate targeted therapies for breast cancer patients.We received funding from the Spanish Ministry of Economy and Competitiveness, Plan Nacional Project SAF 2013-42497-P; Centro de Excelencia Severo Ochoa 2013–2017; the Centre de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya; G.V. has received funding from the Spanish Ministry of Economy and Competitiveness, “Juan de la Cierva Incorporation” fellowship (Ref. IJCI-2014-20723), the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement Number 299429 and the European Molecular Biology Organization (EMBO long-term fellowship ALTF 1106-2011, cofunded with the European Commission EMBOCOFUND2010, GA-2010-267146).MDPI201920192018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/42572http://dx.doi.org/10.3390/cancers10100371reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésCancers (Basel). 2018;10(10):371info:eu-repo/grantAgreement/EC/FP7/299429info:eu-repo/grantAgreement/ES/1PE/SAF2013-42497-P© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/425722026-06-12T07:21:37Z |
| dc.title.none.fl_str_mv |
Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cells |
| title |
Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cells |
| spellingShingle |
Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cells Verde, Gaetano DNA methylation Breast cancer Endocrine therapy Estrogen receptor Gene expression Progesterone receptor |
| title_short |
Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cells |
| title_full |
Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cells |
| title_fullStr |
Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cells |
| title_full_unstemmed |
Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cells |
| title_sort |
Unliganded progesterone receptor governs estrogen receptor gene expression by regulating DNA methylation in breast cancer cells |
| dc.creator.none.fl_str_mv |
Verde, Gaetano De Llobet, Lara Isabel Wright, Roni H.G. Quilez Oliete, Javier Peiró Sales, Sandra Le Dily, François Beato, Miguel |
| author |
Verde, Gaetano |
| author_facet |
Verde, Gaetano De Llobet, Lara Isabel Wright, Roni H.G. Quilez Oliete, Javier Peiró Sales, Sandra Le Dily, François Beato, Miguel |
| author_role |
author |
| author2 |
De Llobet, Lara Isabel Wright, Roni H.G. Quilez Oliete, Javier Peiró Sales, Sandra Le Dily, François Beato, Miguel |
| author2_role |
author author author author author author |
| dc.subject.none.fl_str_mv |
DNA methylation Breast cancer Endocrine therapy Estrogen receptor Gene expression Progesterone receptor |
| topic |
DNA methylation Breast cancer Endocrine therapy Estrogen receptor Gene expression Progesterone receptor |
| description |
Breast cancer prognosis and response to endocrine therapy strongly depends on the expression of the estrogen and progesterone receptors (ER and PR, respectively). Although much is known about ERα gene (ESR1) regulation after hormonal stimulation, how it is regulated in hormone-free condition is not fully understood. We used ER-/PR-positive breast cancer cells to investigate the role of PR in ESR1 regulation in the absence of hormones. We show that PR binds to the low-methylated ESR1 promoter and maintains both gene expression and DNA methylation of the ESR1 locus in hormone-deprived breast cancer cells. Depletion of PR reduces ESR1 expression, with a concomitant increase in gene promoter methylation. The high amount of methylation in the ESR1 promoter of PR-depleted cells persists after the stable re-expression of PR and inhibits PR binding to this genomic region. As a consequence, the rescue of PR expression in PR-depleted cells is insufficient to restore ESR1 expression. Consistently, DNA methylation impedes PR binding to consensus progesterone responsive elements. These findings contribute to understanding the complex crosstalk between PR and ER and suggest that the analysis of ESR1 promoter methylation in breast cancer cells can help to design more appropriate targeted therapies for breast cancer patients. |
| publishDate |
2018 |
| dc.date.none.fl_str_mv |
2018 2019 2019 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10230/42572 http://dx.doi.org/10.3390/cancers10100371 |
| url |
http://hdl.handle.net/10230/42572 http://dx.doi.org/10.3390/cancers10100371 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Cancers (Basel). 2018;10(10):371 info:eu-repo/grantAgreement/EC/FP7/299429 info:eu-repo/grantAgreement/ES/1PE/SAF2013-42497-P |
| dc.rights.none.fl_str_mv |
http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
reponame:Repositorio Digital de la UPF instname:Universitat Pompeu Fabra |
| instname_str |
Universitat Pompeu Fabra |
| reponame_str |
Repositorio Digital de la UPF |
| collection |
Repositorio Digital de la UPF |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869415679590924288 |
| score |
15,811543 |